Fig. 1.
Fig. 1. Detection of CBFB-MYH11 fusion transcripts by RT-PCR. (A) Agarose gel electrophoresis of C1-M1 primer set amplification products. (B) Hybridization of PCR products with the inv(16) CBFB internal oligoprobe. In both panels, lane numbers 1 through 6 correspond to samples from PN 14, 13, 22, 1, 18, and 23, respectively (Table 1). Lane 7 represents a relapse sample from PN 23. Lane 8 is a negative control (no RNA). Sample from PN 22 (lane 3) displays a prominent, but slightly smaller PCR product than expected for a type A fusion (∼400 bp in [A]) and does not hybridize with the oligoprobe (B). This PCR product did hybridize positively with a 0.8-kb CBFB cDNA probe (not shown). Lane 4 demonstrates a type D fusion; lanes 6 and 7 show a type C fusion.

Detection of CBFB-MYH11 fusion transcripts by RT-PCR. (A) Agarose gel electrophoresis of C1-M1 primer set amplification products. (B) Hybridization of PCR products with the inv(16) CBFB internal oligoprobe. In both panels, lane numbers 1 through 6 correspond to samples from PN 14, 13, 22, 1, 18, and 23, respectively (Table 1). Lane 7 represents a relapse sample from PN 23. Lane 8 is a negative control (no RNA). Sample from PN 22 (lane 3) displays a prominent, but slightly smaller PCR product than expected for a type A fusion (∼400 bp in [A]) and does not hybridize with the oligoprobe (B). This PCR product did hybridize positively with a 0.8-kb CBFB cDNA probe (not shown). Lane 4 demonstrates a type D fusion; lanes 6 and 7 show a type C fusion.

Close Modal

or Create an Account

Close Modal
Close Modal